Molly A. Silvers - Concepedia

Author

Molly A. Silvers

The University of Texas Southwestern Medical Center ORCID

Also Known As

, Molly A Silvers, Molly A. Silvers, Silvers, Molly A.

Publications

614

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Louisiana State University University of Florida Southwestern Medical Center

About

Molly A. Silvers is an author at The University of Texas Southwestern Medical Center specializing in pharmacology, medicinal chemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Pharmacology	3	3	239
2	Medicine	2	2	161
3	Natural Sciences	2	2	112
4	Biochemistry	1	1	34
5	Chemistry	1	1	78

Molly A. Silvers

Publications

614

Citations

H-Index

Page 1

	Year	Citations
A member of the Phosphate transporter 1 (Pht1) family from the arsenic‐hyperaccumulating fern <i>Pteris vittata</i> is a high‐affinity arsenate transporter Sandra Feuer DiTusa, Elena B. Fontenot, Robert W. Wallace, New Phytologist	2015	173
Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors Xiumei Huang, Edward A. Motea, Zachary Moore, Cancer Cell Nqo1 Bioactivatable DrugTumor BiologyPolymer-drug ConjugateMedicinePharmacology	2016	127
The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism Molly A. Silvers, Naveen Singh, Robert A. Egnatchik, Journal of Biological Chemistry	2017	88
Synthesis and antitumor activity of selenium-containing quinone-based triazoles possessing two redox centres, and their mechanistic insights Eduardo H. G. da Cruz, Molly A. Silvers, Guilherme A. M. Jardim, European Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryHeterocyclicNatural SciencesSelenium-containing Quinone-based Triazoles	2016	78
Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone Gaurab Chakrabarti, Molly A. Silvers, Mariya Ilcheva, Scientific Reports	2015	58
Using a novel NQO1 bioactivatable drug, beta‐lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer Muhammad Shaalan Beg, Xiumei Huang, Molly A. Silvers, Journal of Surgical Oncology	2017	36
Design, Synthesis, and Antibacterial Properties of Dual-Ligand Inhibitors of Acetyl-CoA Carboxylase Molly A. Silvers, Gregory T. Robertson, Carol M. Taylor, Journal of Medicinal Chemistry Antibacterial ActivityDual-ligand InhibitorsPharmaceutical ChemistryAcetyl-coa CarboxylaseDrug Resistance	2014	34
Crystal Structure of Carboxyltransferase from <i>Staphylococcus aureus</i> Bound to the Antibacterial Agent Moiramide B Molly A. Silvers, Svetlana Pakhomova, David B. Neau, Biochemistry	2016	20

Page 1